Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas

Abstract Purpose Frequency and risk profile of radiation necrosis (RN) in patients with glioma undergoing either upfront stereotactic brachytherapy (SBT) and additional salvage external beam radiotherapy (EBRT) after tumor recurrence or vice versa remains unknown. Methods Patients with glioma treate...

Full description

Bibliographic Details
Main Authors:	Indrawati Hadi, Daniel Reitz, Raphael Bodensohn, Olarn Roengvoraphoj, Stefanie Lietke, Maximilian Niyazi, Jörg-Christian Tonn, Claus Belka, Niklas Thon, Silke Birgit Nachbichler
Format:	Article
Language:	English
Published:	BMC 2021-02-01
Series:	Radiation Oncology
Subjects:	Radiation necrosis Stereotactic brachytherapy External beam radiotherapy Re-irradiation Prognostic factors
Online Access:	https://doi.org/10.1186/s13014-021-01762-0

Similar Items

Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01)

Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas
by: Juliana Watson, et al.
Published: (2020-12-01)

Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
by: Indrawati Hadi, et al.
Published: (2020-02-01)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
by: Ruge Maximilian I, et al.
Published: (2012-06-01)

A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
by: Sheng Peng, et al.
Published: (2021-04-01)

Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma
by: Franziska Walter, et al.
Published: (2021-05-01)

125IODINE BRACHYTHERAPY IN THE TREATMENT OF MALIGNANT ORBITAL TUMORS AS A POSSIBLE ALTERNATIVE TO TELEIRRADIATION
by: A. A. Yarovoy, et al.
Published: (2015-04-01)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
by: Thomas Brun, et al.
Published: (2018-10-01)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
by: Elton Trigo Teixeira Leite, et al.

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
by: Wu C, et al.
Published: (2018-10-01)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
by: Chen, J., et al.
Published: (2022)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
by: Du E, et al.
Published: (2017-05-01)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
by: Antonio Piñeiro Ces, et al.
Published: (2021-04-01)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
by: Congxiao Wang, et al.
Published: (2020-06-01)

Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors
by: Han T, et al.
Published: (2017-07-01)

HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
by: Franziska Walter, et al.
Published: (2021-08-01)

Dosimetric Analysis of Template-assisted 192Ir-source Hypofractionated Stereotactic Ablative Brachytherapy for Peripheral Lung Cancer
by: GAO Qin, et al.
Published: (2021-05-01)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
by: Tomoyuki Makino, et al.
Published: (2016-12-01)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
by: Hong Dong, et al.
Published: (2021-05-01)

Radioactive seed migration after prostate brachytherapy with Iodine-125 using loose seeds versus stranded seeds
by: Carlos A. S. Franca, et al.
Published: (2009-10-01)

Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?
by: Bin Liu, et al.
Published: (2020-03-01)

Considerações radiodosimétricas da braquiterapia ocular com iodo-125 e rutênio/ródio-106 Radiodosimetric considerations on ocular brachytherapy with iodine-125 and ruthenium/rhodium-106
by: Arnaldo Prata Mourão, et al.
Published: (2009-02-01)

Long-Term Outcomes of Personalized Stereotactic Ablative Brachytherapy for Recurrent Head and Neck Adenoid Cystic Carcinoma after Surgery or External Beam Radiotherapy: A 9-Year Study
by: Yi Chen, et al.
Published: (2021-08-01)

Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
by: Finbar Slevin, et al.
Published: (2020-12-01)

Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
by: Wu C, et al.
Published: (2020-09-01)

Treatment planning considerations for 125I eye plaque brachytherapy
by: David Miguel, et al.
Published: (2019-06-01)

Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma
by: Duo Hong, et al.
Published: (2021-09-01)

The seven-year preliminary results of brachytherapy with Iodine-125 seeds for localized prostate cancer treated at a Brazilian single-center
by: Carlos A. S. Franca, et al.
Published: (2007-12-01)

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
by: Katsumi Hirose, et al.
Published: (2017-12-01)

Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer
by: Li H, et al.
Published: (2020-09-01)

Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
by: Koichiro Muraki, et al.
Published: (2021-05-01)

The efficacy of iodine-125 interstitial brachytherapy for the treatment of locally advanced adenoid cystic carcinoma of the base of tongue: a non-surgical approach
by: Shuang Dong, et al.
Published: (2021-08-01)

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
by: Menachem Z. Yondorf, et al.
Published: (2020-08-01)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2021-08-01)

Quantification of iodine in porous hydroxyapatite matrices for application as radioactive sources in brachytherapy
by: Kássio André Lacerda, et al.
Published: (2007-07-01)

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival
by: Sophie Robin, et al.
Published: (2021-08-01)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
by: Astrahan, M.A, et al.
Published: (2022)

Advances of 125I Radioactive Particle Chain Intracavitary Brachytherapy
by: YAO Yuan, et al.
Published: (2019-10-01)

Determination of the Dosimetric Characteristics of BATAN’s 125I Source for Brachytherapy: An Experimental Study
by: K.Y.P. Sandy, et al.
Published: (2018-08-01)

Bioevaluation of 125 I Ocu-Prosta seeds for application in prostate cancer brachytherapy
by: Archana Mukherjee, et al.
Published: (2014-01-01)